Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.Anemia, Aplastic: A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements.Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).Fanconi Anemia: Congenital disorder affecting all bone marrow elements, resulting in ANEMIA; LEUKOPENIA; and THROMBOPENIA, and associated with cardiac, renal, and limb malformations as well as dermal pigmentary changes. Spontaneous CHROMOSOME BREAKAGE is a feature of this disease along with predisposition to LEUKEMIA. There are at least 7 complementation groups in Fanconi anemia: FANCA, FANCB, FANCC, FANCD1, FANCD2, FANCE, FANCF, FANCG, and FANCL. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=227650, August 20, 2004)Anemia, Hemolytic, Autoimmune: Acquired hemolytic anemia due to the presence of AUTOANTIBODIES which agglutinate or lyse the patient's own RED BLOOD CELLS.Anemia, Hypochromic: Anemia characterized by a decrease in the ratio of the weight of hemoglobin to the volume of the erythrocyte, i.e., the mean corpuscular hemoglobin concentration is less than normal. The individual cells contain less hemoglobin than they could have under optimal conditions. Hypochromic anemia may be caused by iron deficiency from a low iron intake, diminished iron absorption, or excessive iron loss. It can also be caused by infections or other diseases, therapeutic drugs, lead poisoning, and other conditions. (Stedman, 25th ed; from Miale, Laboratory Medicine: Hematology, 6th ed, p393)Anemia, Macrocytic: Anemia characterized by larger than normal erythrocytes, increased mean corpuscular volume (MCV) and increased mean corpuscular hemoglobin (MCH).Anemia, Pernicious: A megaloblastic anemia occurring in children but more commonly in later life, characterized by histamine-fast achlorhydria, in which the laboratory and clinical manifestations are based on malabsorption of vitamin B 12 due to a failure of the gastric mucosa to secrete adequate and potent intrinsic factor. (Dorland, 27th ed)Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.Anemia, Sideroblastic: Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.Anemia, Megaloblastic: A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.Infectious Anemia Virus, Equine: A species of LENTIVIRUS, subgenus equine lentiviruses (LENTIVIRUSES, EQUINE), causing acute and chronic infection in horses. It is transmitted mechanically by biting flies, mosquitoes, and midges, and iatrogenically through unsterilized equipment. Chronic infection often consists of acute episodes with remissions.Hemoglobins: The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.Anemia, Refractory: A severe sometimes chronic anemia, usually macrocytic in type, that does not respond to ordinary antianemic therapy.Anemia, Hemolytic, Congenital: Hemolytic anemia due to various intrinsic defects of the erythrocyte.Equine Infectious Anemia: Viral disease of horses caused by the equine infectious anemia virus (EIAV; INFECTIOUS ANEMIA VIRUS, EQUINE). It is characterized by intermittent fever, weakness, and anemia. Chronic infection consists of acute episodes with remissions.Erythropoietin: Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.Chicken anemia virus: The type species of GYROVIRUS, a small, non-enveloped DNA virus originally isolated from contaminated vaccines in Japan. It causes chicken infectious anemia and may possibly play a key role in hemorrhagic anemia syndrome, anemia dermatitis, and blue wing disease.Anemia, Dyserythropoietic, Congenital: A familial disorder characterized by ANEMIA with multinuclear ERYTHROBLASTS, karyorrhexis, asynchrony of nuclear and cytoplasmic maturation, and various nuclear abnormalities of bone marrow erythrocyte precursors (ERYTHROID PRECURSOR CELLS). Type II is the most common of the 3 types; it is often referred to as HEMPAS, based on the Hereditary Erythroblast Multinuclearity with Positive Acidified Serum test.Anemia, Diamond-Blackfan: A rare congenital hypoplastic anemia that usually presents early in infancy. The disease is characterized by a moderate to severe macrocytic anemia, occasional neutropenia or thrombocytosis, a normocellular bone marrow with erythroid hypoplasia, and an increased risk of developing leukemia. (Curr Opin Hematol 2000 Mar;7(2):85-94)Fanconi Anemia Complementation Group Proteins: A diverse group of proteins whose genetic MUTATIONS have been associated with the chromosomal instability syndrome FANCONI ANEMIA. Many of these proteins play important roles in protecting CELLS against OXIDATIVE STRESS.Iron: A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN.Pregnancy Complications, Hematologic: The co-occurrence of pregnancy and a blood disease (HEMATOLOGIC DISEASES) which involves BLOOD CELLS or COAGULATION FACTORS. The hematologic disease may precede or follow FERTILIZATION and it may or may not have a deleterious effect on the pregnant woman or FETUS.Anemia, Neonatal: The mildest form of erythroblastosis fetalis in which anemia is the chief manifestation.Hematinics: Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias.Anemia, Refractory, with Excess of Blasts: Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.Fanconi Anemia Complementation Group C Protein: A Fanconi anemia complementation group protein that regulates the activities of CYTOCHROME P450 REDUCTASE and GLUTATHIONE S-TRANSFERASE. It is found predominately in the CYTOPLASM, but moves to the CELL NUCLEUS in response to FANCE PROTEIN.Fanconi Anemia Complementation Group D2 Protein: A Fanconi anemia complementation group protein that undergoes mono-ubiquitination by FANCL PROTEIN in response to DNA DAMAGE. Also, in response to IONIZING RADIATION it can undergo PHOSPHORYLATION by ataxia telangiectasia mutated protein. Modified FANCD2 interacts with BRCA2 PROTEIN in a stable complex with CHROMATIN, and it is involved in DNA REPAIR by homologous RECOMBINATION.Hematocrit: The volume of packed RED BLOOD CELLS in a blood specimen. The volume is measured by centrifugation in a tube with graduated markings, or with automated blood cell counters. It is an indicator of erythrocyte status in disease. For example, ANEMIA shows a low value; POLYCYTHEMIA, a high value.Fanconi Anemia Complementation Group A Protein: A Fanconi anemia complementation group protein that is the most commonly mutated protein in FANCONI ANEMIA. It undergoes PHOSPHORYLATION by PROTEIN KINASE B and forms a complex with FANCC PROTEIN in the CELL NUCLEUS.Erythropoiesis: The production of red blood cells (ERYTHROCYTES). In humans, erythrocytes are produced by the YOLK SAC in the first trimester; by the liver in the second trimester; by the BONE MARROW in the third trimester and after birth. In normal individuals, the erythrocyte count in the peripheral blood remains relatively constant implying a balance between the rate of erythrocyte production and rate of destruction.Anemia, Hemolytic, Congenital Nonspherocytic: Any one of a group of congenital hemolytic anemias in which there is no abnormal hemoglobin or spherocytosis and in which there is a defect of glycolysis in the erythrocyte. Common causes include deficiencies in GLUCOSE-6-PHOSPHATE ISOMERASE; PYRUVATE KINASE; and GLUCOSE-6-PHOSPHATE DEHYDROGENASE.Pallor: A clinical manifestation consisting of an unnatural paleness of the skin.Erythrocyte Count: The number of RED BLOOD CELLS per unit volume in a sample of venous BLOOD.Ferritins: Iron-containing proteins that are widely distributed in animals, plants, and microorganisms. Their major function is to store IRON in a nontoxic bioavailable form. Each ferritin molecule consists of ferric iron in a hollow protein shell (APOFERRITINS) made of 24 subunits of various sequences depending on the species and tissue types.Erythrocyte Indices: ERYTHROCYTE size and HEMOGLOBIN content or concentration, usually derived from ERYTHROCYTE COUNT; BLOOD hemoglobin concentration; and HEMATOCRIT. The indices include the mean corpuscular volume (MCV), the mean corpuscular hemoglobin (MCH), and the mean corpuscular hemoglobin concentration (MCHC).Hemoglobinometry: Measurement of hemoglobin concentration in blood.Blood Transfusion: The introduction of whole blood or blood component directly into the blood stream. (Dorland, 27th ed)Erythrocytes: Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN.Fanconi Anemia Complementation Group G Protein: A Fanconi anemia complementation group protein that undergoes PHOSPHORYLATION by CDC2 PROTEIN KINASE during MITOSIS. It forms a complex with other FANCONI ANEMIA PROTEINS and helps protect CELLS from DNA DAMAGE by genotoxic agents.Coombs Test: A test to detect non-agglutinating ANTIBODIES against ERYTHROCYTES by use of anti-antibodies (the Coombs' reagent.) The direct test is applied to freshly drawn blood to detect antibody bound to circulating red cells. The indirect test is applied to serum to detect the presence of antibodies that can bind to red blood cells.Reticulocyte Count: The number of RETICULOCYTES per unit volume of BLOOD. The values are expressed as a percentage of the ERYTHROCYTE COUNT or in the form of an index ("corrected reticulocyte index"), which attempts to account for the number of circulating erythrocytes.Iron, Dietary: Iron or iron compounds used in foods or as food. Dietary iron is important in oxygen transport and the synthesis of the iron-porphyrin proteins hemoglobin, myoglobin, cytochromes, and cytochrome oxidase. Insufficient amounts of dietary iron can lead to iron-deficiency anemia.Iron Compounds: Organic and inorganic compounds that contain iron as an integral part of the molecule.Hepcidins: Forms of hepcidin, a cationic amphipathic peptide synthesized in the liver as a prepropeptide which is first processed into prohepcidin and then into the biologically active hepcidin forms, including in human the 20-, 22-, and 25-amino acid residue peptide forms. Hepcidin acts as a homeostatic regulators of iron metabolism and also possesses antimicrobial activity.Erythrocytes, Abnormal: Oxygen-carrying RED BLOOD CELLS in mammalian blood that are abnormal in structure or function.Erythrocyte Transfusion: The transfer of erythrocytes from a donor to a recipient or reinfusion to the donor.Prevalence: The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.Vitamin B 12 Deficiency: A nutritional condition produced by a deficiency of VITAMIN B 12 in the diet, characterized by megaloblastic anemia. Since vitamin B 12 is not present in plants, humans have obtained their supply from animal products, from multivitamin supplements in the form of pills, and as additives to food preparations. A wide variety of neuropsychiatric abnormalities is also seen in vitamin B 12 deficiency and appears to be due to an undefined defect involving myelin synthesis. (From Cecil Textbook of Medicine, 19th ed, p848)Erythrocyte Aging: The senescence of RED BLOOD CELLS. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.Bone Marrow: The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells.beta-Thalassemia: A disorder characterized by reduced synthesis of the beta chains of hemoglobin. There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent.Isavirus: A genus in the family ORTHOMYXOVIRIDAE containing one species: Infectious salmon anemia virus.Pancytopenia: Deficiency of all three cell elements of the blood, erythrocytes, leukocytes and platelets.Thalassemia: A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia.Fanconi Anemia Complementation Group F Protein: A Fanconi anemia complementation group protein. It is an essential component of a nuclear core complex that protects the GENOME against CHROMOSOMAL INSTABILITY. It interacts directly with FANCG PROTEIN and helps stabilize a complex with FANCA PROTEIN and FANCC PROTEIN.Phenylhydrazines: Diazo derivatives of aniline, used as a reagent for sugars, ketones, and aldehydes. (Dorland, 28th ed)Fanconi Anemia Complementation Group E Protein: A Fanconi anemia complementation group protein that interacts with FANCC PROTEIN and FANCD2 PROTEIN. It promotes the accumulation of FANCC protein in the CELL NUCLEUS.Fetal Hemoglobin: The major component of hemoglobin in the fetus. This HEMOGLOBIN has two alpha and two gamma polypeptide subunits in comparison to normal adult hemoglobin, which has two alpha and two beta polypeptide subunits. Fetal hemoglobin concentrations can be elevated (usually above 0.5%) in children and adults affected by LEUKEMIA and several types of ANEMIA.Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.Blood Cell Count: The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES.Treatment Outcome: Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.Folic Acid Deficiency: A nutritional condition produced by a deficiency of FOLIC ACID in the diet. Many plant and animal tissues contain folic acid, abundant in green leafy vegetables, yeast, liver, and mushrooms but destroyed by long-term cooking. Alcohol interferes with its intermediate metabolism and absorption. Folic acid deficiency may develop in long-term anticonvulsant therapy or with use of oral contraceptives. This deficiency causes anemia, macrocytic anemia, and megaloblastic anemia. It is indistinguishable from vitamin B 12 deficiency in peripheral blood and bone marrow findings, but the neurologic lesions seen in B 12 deficiency do not occur. (Merck Manual, 16th ed)Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.Vitamin B 12: A cobalt-containing coordination compound produced by intestinal micro-organisms and found also in soil and water. Higher plants do not concentrate vitamin B 12 from the soil and so are a poor source of the substance as compared with animal tissues. INTRINSIC FACTOR is important for the assimilation of vitamin B 12.Horses: Large, hoofed mammals of the family EQUIDAE. Horses are active day and night with most of the day spent seeking and consuming food. Feeding peaks occur in the early morning and late afternoon, and there are several daily periods of rest.Splenomegaly: Enlargement of the spleen.Erythroblasts: Immature, nucleated ERYTHROCYTES occupying the stage of ERYTHROPOIESIS that follows formation of ERYTHROID PRECURSOR CELLS and precedes formation of RETICULOCYTES. The normal series is called normoblasts. Cells called MEGALOBLASTS are a pathologic series of erythroblasts.Osmotic Fragility: RED BLOOD CELL sensitivity to change in OSMOTIC PRESSURE. When exposed to a hypotonic concentration of sodium in a solution, red cells take in more water, swell until the capacity of the cell membrane is exceeded, and burst.Reticulocytes: Immature ERYTHROCYTES. In humans, these are ERYTHROID CELLS that have just undergone extrusion of their CELL NUCLEUS. They still contain some organelles that gradually decrease in number as the cells mature. RIBOSOMES are last to disappear. Certain staining techniques cause components of the ribosomes to precipitate into characteristic "reticulum" (not the same as the ENDOPLASMIC RETICULUM), hence the name reticulocytes.Antilymphocyte Serum: Serum containing GAMMA-GLOBULINS which are antibodies for lymphocyte ANTIGENS. It is used both as a test for HISTOCOMPATIBILITY and therapeutically in TRANSPLANTATION.Parasitemia: The presence of parasites (especially malarial parasites) in the blood. (Dorland, 27th ed)Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Ferrous Compounds: Inorganic or organic compounds that contain divalent iron.Recombinant Proteins: Proteins prepared by recombinant DNA technology.Iron Overload: An excessive accumulation of iron in the body due to a greater than normal absorption of iron from the gastrointestinal tract or from parenteral injection. This may arise from idiopathic hemochromatosis, excessive iron intake, chronic alcoholism, certain types of refractory anemia, or transfusional hemosiderosis. (From Churchill's Illustrated Medical Dictionary, 1989)Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.Heinz Bodies: Abnormal intracellular inclusions, composed of denatured hemoglobin, found on the membrane of red blood cells. They are seen in thalassemias, enzymopathies, hemoglobinopathies, and after splenectomy.Hookworm Infections: Infection of humans or animals with hookworms other than those caused by the genus Ancylostoma or Necator, for which the specific terms ANCYLOSTOMIASIS and NECATORIASIS are available.Receptors, Transferrin: Membrane glycoproteins found in high concentrations on iron-utilizing cells. They specifically bind iron-bearing transferrin, are endocytosed with its ligand and then returned to the cell surface where transferrin without its iron is released.Hemoglobinopathies: A group of inherited disorders characterized by structural alterations within the hemoglobin molecule.Thrombocytopenia: A subnormal level of BLOOD PLATELETS.Hemoglobin, Sickle: An abnormal hemoglobin resulting from the substitution of valine for glutamic acid at position 6 of the beta chain of the globin moiety. The heterozygous state results in sickle cell trait, the homozygous in sickle cell anemia.Malaria, Falciparum: Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations.Intrinsic Factor: A glycoprotein secreted by the cells of the GASTRIC GLANDS that is required for the absorption of VITAMIN B 12 (cyanocobalamin). Deficiency of intrinsic factor leads to VITAMIN B 12 DEFICIENCY and ANEMIA, PERNICIOUS.alpha-Thalassemia: A disorder characterized by reduced synthesis of the alpha chains of hemoglobin. The severity of this condition can vary from mild anemia to death, depending on the number of genes deleted.Spherocytosis, Hereditary: A group of familial congenital hemolytic anemias characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. The erythrocytes have increased osmotic fragility and are abnormally permeable to sodium ions.Rh Isoimmunization: The process by which fetal Rh+ erythrocytes enter the circulation of an Rh- mother, causing her to produce IMMUNOGLOBULIN G antibodies, which can cross the placenta and destroy the erythrocytes of Rh+ fetuses. Rh isoimmunization can also be caused by BLOOD TRANSFUSION with mismatched blood.Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)Antimicrobial Cationic Peptides: Small cationic peptides that are an important component, in most species, of early innate and induced defenses against invading microbes. In animals they are found on mucosal surfaces, within phagocytic granules, and on the surface of the body. They are also found in insects and plants. Among others, this group includes the DEFENSINS, protegrins, tachyplesins, and thionins. They displace DIVALENT CATIONS from phosphate groups of MEMBRANE LIPIDS leading to disruption of the membrane.Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.Tanzania: A republic in eastern Africa, south of UGANDA and north of MOZAMBIQUE. Its capital is Dar es Salaam. It was formed in 1964 by a merger of the countries of TANGANYIKA and ZANZIBAR.Infant, Newborn: An infant during the first month after birth.Retrospective Studies: Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.Erythroid Precursor Cells: The cells in the erythroid series derived from MYELOID PROGENITOR CELLS or from the bi-potential MEGAKARYOCYTE-ERYTHROID PROGENITOR CELLS which eventually give rise to mature RED BLOOD CELLS. The erythroid progenitor cells develop in two phases: erythroid burst-forming units (BFU-E) followed by erythroid colony-forming units (CFU-E); BFU-E differentiate into CFU-E on stimulation by ERYTHROPOIETIN, and then further differentiate into ERYTHROBLASTS when stimulated by other factors.Pregnancy Complications, Parasitic: The co-occurrence of pregnancy and parasitic diseases. The parasitic infection may precede or follow FERTILIZATION.Antisickling Agents: Agents used to prevent or reverse the pathological events leading to sickling of erythrocytes in sickle cell conditions.Parvovirus B19, Human: The type species of ERYTHROVIRUS and the etiological agent of ERYTHEMA INFECTIOSUM, a disease most commonly seen in school-age children.Folic Acid: A member of the vitamin B family that stimulates the hematopoietic system. It is present in the liver and kidney and is found in mushrooms, spinach, yeast, green leaves, and grasses (POACEAE). Folic acid is used in the treatment and prevention of folate deficiencies and megaloblastic anemia.Pica: The persistent eating of nonnutritive substances for a period of at least one month. (DSM-IV)Nutritional Status: State of the body in relation to the consumption and utilization of nutrients.Hemoglobins, Abnormal: Hemoglobins characterized by structural alterations within the molecule. The alteration can be either absence, addition or substitution of one or more amino acids in the globin part of the molecule at selected positions in the polypeptide chains.Parvoviridae Infections: Virus infections caused by the PARVOVIRIDAE.Hemoglobinuria, Paroxysmal: A condition characterized by the recurrence of HEMOGLOBINURIA caused by intravascular HEMOLYSIS. In cases occurring upon cold exposure (paroxysmal cold hemoglobinuria), usually after infections, there is a circulating antibody which is also a cold hemolysin. In cases occurring during or after sleep (paroxysmal nocturnal hemoglobinuria), the clonal hematopoietic stem cells exhibit a global deficiency of cell membrane proteins.Malnutrition: An imbalanced nutritional status resulted from insufficient intake of nutrients to meet normal physiological requirement.Cross-Sectional Studies: Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time.Prospective Studies: Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.Splenectomy: Surgical procedure involving either partial or entire removal of the spleen.Glucosephosphate Dehydrogenase Deficiency: A disease-producing enzyme deficiency subject to many variants, some of which cause a deficiency of GLUCOSE-6-PHOSPHATE DEHYDROGENASE activity in erythrocytes, leading to hemolytic anemia.Hematologic Diseases: Disorders of the blood and blood forming tissues.Transferrin: An iron-binding beta1-globulin that is synthesized in the LIVER and secreted into the blood. It plays a central role in the transport of IRON throughout the circulation. A variety of transferrin isoforms exist in humans, including some that are considered markers for specific disease states.Reticulocytosis: An increase in circulating RETICULOCYTES, which is among the simplest and most reliable signs of accelerated ERYTHROCYTE production. Reticulocytosis occurs during active BLOOD regeneration (stimulation of red bone marrow) and in certain types of ANEMIA, particularly CONGENITAL HEMOLYTIC ANEMIA.Renal Dialysis: Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION.Kenya: A republic in eastern Africa, south of ETHIOPIA, west of SOMALIA with TANZANIA to its south, and coastline on the Indian Ocean. Its capital is Nairobi.Bone Marrow DiseasesHematologic Tests: Tests used in the analysis of the hemic system.Sickle Cell Trait: The condition of being heterozygous for hemoglobin S.Salmo salar: A commercially important species of SALMON in the family SALMONIDAE, order SALMONIFORMES, which occurs in the North Atlantic.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Blood Transfusion, Intrauterine: In utero transfusion of BLOOD into the FETUS for the treatment of FETAL DISEASES, such as fetal erythroblastosis (ERYTHROBLASTOSIS, FETAL).Severity of Illness Index: Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.5-Aminolevulinate Synthetase: An enzyme of the transferase class that catalyzes condensation of the succinyl group from succinyl coenzyme A with glycine to form delta-aminolevulinate. It is a pyridoxyal phosphate protein and the reaction occurs in mitochondria as the first step of the heme biosynthetic pathway. The enzyme is a key regulatory enzyme in heme biosynthesis. In liver feedback is inhibited by heme. EC 2.3.1.37.Dietary Supplements: Products in capsule, tablet or liquid form that provide dietary ingredients, and that are intended to be taken by mouth to increase the intake of nutrients. Dietary supplements can include macronutrients, such as proteins, carbohydrates, and fats; and/or MICRONUTRIENTS, such as VITAMINS; MINERALS; and PHYTOCHEMICALS.Thrombocytosis: Increased numbers of platelets in the peripheral blood. (Dorland, 27th ed)Oxymetholone: A synthetic hormone with anabolic and androgenic properties. It is used mainly in the treatment of anemias. According to the Fourth Annual Report on Carcinogens (NTP 85-002), this compound may reasonably be anticipated to be a carcinogen. (From Merck Index, 11th ed)Follow-Up Studies: Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.Hemoglobin E: An abnormal hemoglobin that results from the substitution of lysine for glutamic acid at position 26 of the beta chain. It is most frequently observed in southeast Asian populations.Red-Cell Aplasia, Pure: Suppression of erythropoiesis with little or no abnormality of leukocyte or platelet production.Glucaric Acid: A sugar acid derived from D-glucose in which both the aldehydic carbon atom and the carbon atom bearing the primary hydroxyl group are oxidized to carboxylic acid groups.Hematopoiesis: The development and formation of various types of BLOOD CELLS. Hematopoiesis can take place in the BONE MARROW (medullary) or outside the bone marrow (HEMATOPOIESIS, EXTRAMEDULLARY).Bone Marrow Transplantation: The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION.Erythroblastosis, Fetal: A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN.Protoporphyrins: Porphyrins with four methyl, two vinyl, and two propionic acid side chains attached to the pyrrole rings. Protoporphyrin IX occurs in hemoglobin, myoglobin, and most of the cytochromes.Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.Immunosuppressive Agents: Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging.Iron Isotopes: Stable iron atoms that have the same atomic number as the element iron, but differ in atomic weight. Fe-54, 57, and 58 are stable iron isotopes.Drug Administration Schedule: Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.Food, Fortified: Any food that has been supplemented with essential nutrients either in quantities that are greater than those present normally, or which are not present in the food normally. Fortified food includes also food to which various nutrients have been added to compensate for those removed by refinement or processing. (From Segen, Dictionary of Modern Medicine, 1992)Bone Marrow Examination: Removal of bone marrow and evaluation of its histologic picture.Mutation: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.Ghana: A republic in western Africa, south of BURKINA FASO and west of TOGO. Its capital is Accra.

Neutrophil functions in patients with inherited bone marrow failure syndromes. (1/1)

 (+info)

/PRNewswire/ -- At no charge whatsoever to the family, this Cryo-Save program has made it possible to treat this congenital anaemia, classified as a rare...
The latest electronic edition of the journal Nature Genetics reports the discovery of a new gene responsible for congenital sideroblastic anemia.
Diamond-Blackfan anemia (DBA) is a severe congenital anemia characterized by a defect in red blood cell production. The disease is associated with growth retardation, malformations, a predisposition for malignant disease and heterozygous mutations in either of the ribosomal protein (RP) genes RPS7, RPS17, RPS19, RPS24, RPL5, RPL11 and RPL35a.In a cellular model for DBA, siRNA knock-down of RPS19 results in a relative decrease of other ribosomal (r) proteins belonging to the small subunit (RPS20, RPS21, RPS24) when compared to r-proteins from the large ribosomal subunit (RPL3, RPL9, RPL30, RPL38). RPS19 mutant cells from DBA patients show a similar and coordinated down-regulation of small subunit proteins. The mRNA levels of the small subunit r-proteins remain relatively unchanged. We also show that RPS19 has an extensive number of transcriptional start sites resulting in mRNAs of variable 5UTR length. The short variants are translated more efficiently. Structural sequence variations in the ...
Abstract. Patients with inherited bone marrow failure syndromes (IBMFSs) classically present with specific patterns of cytopenias along with congenital anomali
Scientists recommend testing for Pearson syndrome in patients with congenital anemia. Some babies diagnosed with and treated for a bone marrow failure disorder, called Diamond Blackfan Anemia, may actually be affected by a very rare anemia syndrome that has a different disease course and treatment, say scientists from Dana-Farber/Boston Childrens Cancer and Blood Disorders Center.. Genetic analysis of DNA from 175 patients believed to have Diamond Blackfan Anemia, identified eight that showed hallmarks of Pearson Marrow Pancreas syndrome, according to research presented at the 55th annual meeting of the American Society of Hematology.. The treatment choices are difficult in both syndromes, but getting the diagnosis correct is crucial, said Suneet Agarwal, MD, PhD, a pediatric hematologist/oncologist at Dana-Farber/Boston Childrens. "Some patients with Diamond Blackfan will respond to steroids, but theres no reason to give steroids to someone with Pearson Syndrome -- and they could make things ...
Background:. A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders.. Mutations in IBMFS genes are relevant to carcinogenesis in sporadic cancers.. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer.. These cancer-prone families are well suited for cancer screening and prevention trials targeting those at increased genetic risk of cancer.. Carriers of IBMFS gene mutations are at increased risk of cancer.. The prototype disorder is Fanconis Anemia (FA); other IBMFS will also be studied.. Objectives:. To determine the types and incidence of specific cancers in patients with an IBMFS.. To investigate the relevance of IBMFS gene mutations in the carcinogenesis pathway of the sporadic counterparts of IBMFS-associated cancers.. To identify risk factors for IBMFS-related cancers in addition to the primary germline ...
Background:. A prospective cohort of Inherited Bone Marrow Failure Syndrome (IBMFS) will provide new information regarding cancer rates and types in these disorders.. Mutations in IBMFS genes are relevant to carcinogenesis in sporadic cancers.. Patients with IBMFS who develop cancer differ in their genetic and/or environmental features from patients with IBMFS who do not develop cancer.. These cancer-prone families are well suited for cancer screening and prevention trials targeting those at increased genetic risk of cancer.. Carriers of IBMFS gene mutations are at increased risk of cancer.. The prototype disorder is Fanconis Anemia (FA); other IBMFS will also be studied.. Objectives:. To determine the types and incidence of specific cancers in patients with an IBMFS.. To investigate the relevance of IBMFS gene mutations in the carcinogenesis pathway of the sporadic counterparts of IBMFS-associated cancers.. To identify risk factors for IBMFS-related cancers in addition to the primary germline ...
Inherited bone marrow failure (IBMF) syndromes are a heterogeneous group of rare hematological disorders characterized by the impairment of hematopoiesis, which harbor specific clinical presentations and pathogenic mechanisms. Some of these syndromes may progress through clonal evolution, myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Most prominent are failures of DNA repair such as Fanconi Anemia and much rarer failure of ribosomal apparatus, e.g., Diamond Blackfan Anemia or...
Diamond-Blackfan anaemia (DBA) is a rare cause of bone marrow failure. The incidence of malignancy and endocrine complications are increased in DBA, relative to other inherited bone marrow failure syndromes. We describe an adult woman with DBA who developed osteoporosis and avascular necrosis (AVN) of both distal femora. Such endocrine complications are not uncommon in DBA, but under-appreciated, especially in adulthood. Further, rectal adenocarcinoma was diagnosed at age 32 years, requiring hemi-colectomy and adjuvant chemotherapy. Elevated cancer risk may warrant disease-specific screening guidelines. Genetic predictors of extra-haematopoetic complications in DBA are yet to be established. ...
Diamond-Blackfan anaemia (DBA) is a rare cause of bone marrow failure. The incidence of malignancy and endocrine complications are increased in DBA, relative to other inherited bone marrow failure syndromes. We describe an adult woman with DBA who developed osteoporosis and avascular necrosis (AVN) of both distal femora. Such endocrine complications are not uncommon in DBA, but under-appreciated, especially in adulthood. Further, rectal adenocarcinoma was diagnosed at age 32 years, requiring hemi-colectomy and adjuvant chemotherapy. Elevated cancer risk may warrant disease-specific screening guidelines. Genetic predictors of extra-haematopoetic complications in DBA are yet to be established. ...
Fanconi anemia (FA) is an inherited bone marrow failure syndrome characterized by pancytopenia, predisposition to malignancy, and physical abnormalities including short stature, microcephaly, developmental delay, café-au-lait skin lesions, and malfor
Glader BE, Backer K, Diamond LK (Dec 1983). "Elevated erythrocyte adenosine deaminase activity in congenital hypoplastic anemia ... Conversely, mutations causing this enzyme to be overexpressed are one cause of hemolytic anemia . There is some evidence that a ... a marker of disordered erythropoiesis in Diamond-Blackfan anaemia and other haematologic diseases". British Journal of ... "Elevated adenosine deaminase activity and hereditary hemolytic anemia. Evidence for abnormal translational control of protein ...
"Effect of subcutaneous deferoxamine and oral vitamin C on iron excretion in congenital hypoplastic anemia and refractory anemia ... with β-thalassemia trait should be warned that their condition can be misdiagnosed for the common Iron deficiency anemia. They ...
Anemia Anemia, Diamond-Blackfan Anemia, hypoplastic, congenital Anemia, pernicious Anemia, sideroblastic Anemia sideroblastic ... congenital Adrenal hyperplasia Adrenal hypertension Adrenal hypoplasia congenital, X-linked Adrenal hypoplasia Adrenal ... congenital Antisocial personality disorder Antisynthetase syndrome Antithrombin deficiency, congenital Antley-Bixler syndrome ... anemia due to Adenylosuccinate lyase deficiency Adie syndrome Adiposis dolorosa, aka Dercum's disease Adolescent benign focal ...
... anemia, aplastic MeSH C15.378.190.196.080 --- anemia, hypoplastic, congenital MeSH C15.378.190.196.080.090 --- anemia, diamond- ... File "2006 MeSH Trees".) MeSH C15.378.071.085 --- anemia, aplastic MeSH C15.378.071.085.080 --- anemia, hypoplastic, congenital ... anemia, hemolytic, congenital MeSH C15.378.071.141.150.095 --- anemia, dyserythropoietic, congenital MeSH C15.378.071.141. ... 150.100 --- anemia, hemolytic, congenital nonspherocytic MeSH C15.378.071.141.150.150 --- anemia, sickle cell MeSH C15.378. ...
... (or Benjamin anemia) is a type of multiple congenital anomaly/intellectual disability (MCA/MR) syndrome. It ... Symptoms include megalocephaly, external ear deformities, dental caries, micromelia, hypoplastic bone deformities, hypogonadism ... hypochromic anemia with occasional tumors, and mental retardation. Firkin, Barry G.; Whitworth, Judith A. (2001). Dictionary of ... is characterized by hypochromic anemia with mental deficiency and various craniofacial and other anomalies. It can also include ...
In newborns, X-rays readily distinguish hypophosphatasia from osteogenesis imperfecta and congenital dwarfism. Some stillborn ... hypoplastic). Ultimately, this leads to respiratory failure. Epilepsy (seizures) can occur and can prove lethal. Regions of ... developing, unmineralized bone (osteoid) may expand and encroach on the marrow space, resulting in myelophthisic anemia. In ... perinatal hypophosphatasia can be distinguished from even the most severe forms of osteogenesis imperfecta and congenital ...
... (or constitutional aplastic anemia) is a type of aplastic anemia which is primarily due to a ... Examples include: Fanconi anemia Diamond-Blackfan anemia Online Mendelian Inheritance in Man (OMIM) 609135. ... congenital disorder. Associated genes include TERC, TERT, IFNG, NBS1, PRF1, and SBDS. ...
Diamond LK, Allen DW, Magill FB (1961). "Congenital (erythroid) hypoplastic anemia: a 25 year study". Am. J. Dis. Child. 102 (3 ... who described congenital hypoplastic anemia in 1938. Responsiveness to corticosteroids was reported in 1951. In 1961, Diamond ... UK Diamond Blackfan Anaemia Charity Diamond Blackfan Anæmia International Support Group Diamond Blackfan Anemia Registry of ... Diamond-Blackfan anemia (DBA) is a congenital erythroid aplasia that usually presents in infancy. DBA causes low red blood cell ...
... such as Turner's hypoplasia Chambers of the heart in hypoplastic left heart syndrome and hypoplastic right heart syndrome Optic ... It is technically not the opposite of hyperplasia (too many cells). Hypoplasia is a congenital condition, while hyperplasia ... Breasts during puberty Testes in Klinefelter's syndrome Ovaries in Fanconi anemia, gonadal dysgenesis, trisomy X Thymus in ... Hypoplasia (from Ancient Greek ὑπo- hypo-, "under" + πλάσις plasis, "formation"; adjective form hypoplastic) is ...
AR Anemia, congenital dyserythropoietic, type I; 224120; CDAN1 Anemia, dyserythropoietic congenital, type II; 224100; SEC23B ... hypomaturation-hypoplastic type, with taurodontism; 104510; DLX3 Amelogenesis imperfecta, hypoplastic/hypomaturation type; ... SCN5A Heinz body anemia; 140700; HBA2 Heinz body anemias, alpha-; 140700; HBA1 Heinz body anemias, beta-; 140700; HBB HELLP ... RPL5 Diamond-Blackfan anemia 7; 612562; RPL11 Diamond-Blackfan anemia 8; 612563; RPS7 Diamond-Blackfan anemia 9; 613308; RPS10 ...
Idiopathic aplastic anaemia (D61.8) Other specified aplastic anaemias (D61.9) Aplastic anaemia, unspecified Hypoplastic anaemia ... congenital) (hereditary) (D58.2) Other haemoglobinopathies Abnormal haemoglobin NOS Congenital Heinz body anaemia ... Constitutional aplastic anaemia Blackfan-Diamond syndrome Familial hypoplastic anaemia Fanconi's anaemia Pancytopenia with ... Congenital dyserythropoietic anaemia (D64.8) Other specified anaemias (D64.9) Anaemia, unspecified (D65) Disseminated ...
Hypoplastic left heart syndrome Hypoplastic right heart microcephaly Hypoplastic thumb mullerian aplasia Hypoplastic thumbs ... congenital Hillig syndrome Hing-Torack-Dowston syndrome Hinson-Pepys disease Hip dislocation Hip dysplasia Beukes type Hip ... Hereditary t Hereditary nodular heterotopia Hereditary non-spherocytic hemolytic anemia Hereditary pancreatitis Hereditary ... congenital essential Hemeralopia, familial Hemi 3 syndrome Hemifacial atrophy agenesis of the caudate nucleus Hemifacial ...
Limb defects occur in up to 70 percent of babies with VACTERL association and include a displaced or hypoplastic thumb, extra ... Up to 75 percent of patients with VACTERL association have been reported to have congenital heart disease.[citation needed] The ... Baller-Gerold syndrome CHARGE syndrome Currarino syndrome DiGeorge Syndrome Fanconi anemia Feingold syndrome Fryns syndrome ... Fifteen percent to 33 percent of patients with TE fistulas will also have congenital heart disease. However these babies ...
... pigmentosa diabetes mellitus Muscular dystrophy congenital infantile cataract hypogonadism Muscular dystrophy congenital, ... meningococcal Meningitis Meningocele Meningococcemia Meningoencephalocele Meningoencephalocele-arthrogryposis-hypoplastic thumb ... ophthalmoplegia hypoacousia areflexia Myopathy tubular aggregates Myopathy with lactic acidosis and sideroblastic anemia ... congenital Mirhosseini-Holmes-Walton syndrome Mirror hands feet nasal defects Mirror polydactyly segmentation and limbs defects ...
Manske PR, Goldfarb CA (2009). "Congenital failure of formation of the upper limb". Hand Clin. 25 (2): 157-70. doi:10.1016/j. ... Hypoplastic radius in miniature Type III: Absent distal radius Type IV: Complete absent radius Type V: Complete absent radius ... the gastrointestinal VATER syndrome and the hematologic Fanconi anemia and TAR syndrome. Other possible causes are an injury to ... Radial dysplasia, also known as radial club hand or radial longitudinal deficiency, is a congenital difference occurring in a ...
Congenital erythropoietic porphyria (Gunther disease) is a rare congenital form of porphyria, and may be associated with red or ... More severe cases show severely hypoplastic patches of enamel, which are also prone to accumulation of surface stains. ... One such condition is hemolytic disease of the newborn (erythroblastosis fetalis). Thalassemia and sickle cell anemia may be ...
These are known as cyanotic congenital heart defects and are often more serious. Major congenital heart defects are often ... These often include a full blood count investigating for anaemia, and basic metabolic panel that may reveal any disturbances in ... hypoplastic left heart syndrome). Common abnormalities include those that affect the heart muscle that separates the two side ... More minor forms of congenital heart disease may remain undetected for many years and only reveal themselves in adult life (e.g ...
Hypoplastic left heart syndrome - Defect in the development of the left heart such that it is hypoplastic (under developed). ... Uhl anomaly - A congenital heart defect in which the right ventricular myocardium is too thin or absent. It is a very rare ... The main cause of angina is coronary artery disease, but can result from other non-atherosclerotic causes such as anemia and ... Ebstein's anomaly - A congenital heart defect that results in the tricuspid valve leaflets being deeper in the heart (toward ...
... congenital MeSH C16.320.070.100 --- anemia, hemolytic, congenital nonspherocytic MeSH C16.320.070.150 --- anemia, sickle cell ... hypoplastic left heart syndrome MeSH C16.131.240.400.685 --- leopard syndrome MeSH C16.131.240.400.701 --- levocardia MeSH ... anemia, diamond-blackfan MeSH C16.320.077.280 --- fanconi anemia MeSH C16.320.099.037 --- activated protein c resistance MeSH ... congenital MeSH C16.131.621.551 --- klippel-feil syndrome MeSH C16.131.621.585 --- limb deformities, congenital MeSH C16.131. ...
... lipodystrophy Congenital insensitivity to pain Congenital myasthenic syndrome Congenital nephrotic syndrome Congenital rubella ... Hyperventilation syndrome Hyperviscosity syndrome Hypohidrotic ectodermal dysplasia Hypoplastic left heart syndrome Hypoplastic ... lysis syndrome Tumor necrosis factor receptor associated periodic syndrome Turner syndrome Twiddler's syndrome Twin Anemia- ... syndrome Complex regional pain syndrome Computer vision syndrome Congenital bilateral perisylvian syndrome Congenital ...
... (AI) is a congenital disorder that presents with a rare abnormal formation of the enamel[1] or external ... Type 1 - Hypoplastic. Enamel of abnormal thickness due to malfunction in enamel matrix formation. Enamel is very thin but hard ... X-linked sideroblastic anemia. Endocrine. *Androgen insensitivity syndrome/Spinal and bulbar muscular atrophy ... Type 4: Hypomature hypoplastic enamel with taurodontism. Enamel has a variation in appearance, with mixed features from Type 1 ...
TSHR (Congenital hypothyroidism 1). *LHCGR (Luteinizing hormone insensitivity, Leydig cell hypoplasia, Male-limited precocious ... Sickle-cell anemia is also considered a recessive condition, but heterozygous carriers have increased resistance to malaria in ... Birth defects are also called congenital anomalies. Autosomal recessive[edit]. Main article: Autosomal dominant § Autosomal ... Most congenital metabolic disorders known as inborn errors of metabolism result from single-gene defects. ...
X-linked sideroblastic anemia. Endocrine. *Androgen insensitivity syndrome/Spinal and bulbar muscular atrophy ... Hypoplastic left heart syndrome. *GJB1 *Charcot-Marie-Tooth disease X1. *GJB2 *Keratitis-ichthyosis-deafness syndrome ...
AAS were the mainstay of therapy for hypoplastic anemias due to leukemia or kidney failure, especially aplastic anemia.[9] AAS ... In support of the model is the rare condition congenital 5α-reductase deficiency, in which the 5α-reductase enzyme is defective ... anabolic ratio are preferred for anemia and osteoporosis, and to reverse protein loss following trauma, surgery, or prolonged ...
Anemia: Central venous hemoglobin , 13 g/dL or capillary hemoglobin , 14.5 g/dL in infant , 34 weeks and 0-28 days old Average ... Neonatal Anemia. Kirsten E. Crowley, MD June 2005. Definitions. ... marrow aspiration for congenital hypoplastic or aplastic anemia ... Fanconi Anemia Erica Antell -. what is fanconi anemia?. fanconi anemia is one of the inherited anemias that causes bone marrow ... Fanconi Anemia Erica Antell -. what is fanconi anemia?. fanconi anemia is one of the inherited anemias that causes bone marrow ...
Anemia, fever - Yes Yes Yes - Yes Antibody Present case. 33. Female. Fever, fatigue, nausea, anemia. -. Yes. Yes. Yes. -. Yes. ... Cohen H,Walker H,Delhanty JD,Lucas SB,Huehns ER,Congenital spherocytosis, B19 parvovirus infection and inherited interstitial ... Catton MG,Thomas SM,Blacklock HA,Croxson MC,Hypoplastic crisis with persistent arthralgia and prolonged parvovirus B19 viraemia ... Fever, jaundice, anemia Yes Yes Yes - - - Immunoelectrophoresis [11] 18 Male Vomiting, fever, lethargy Yes Yes - - - - Antibody ...
Congenital hypoplastic anemia (or constitutional aplastic anemia) is a type of aplastic anemia which is primarily due to a ... Examples include: Fanconi anemia Diamond-Blackfan anemia Online Mendelian Inheritance in Man (OMIM) 609135. ... congenital disorder. Associated genes include TERC, TERT, IFNG, NBS1, PRF1, and SBDS. ...
Anemias, Congenital Hypoplastic. An inborn condition characterized by deficiencies of red Cell precursors that sometimes also ...
What is familial hypoplastic anemia? Meaning of familial hypoplastic anemia medical term. What does familial hypoplastic anemia ... Looking for online definition of familial hypoplastic anemia in the Medical Dictionary? familial hypoplastic anemia explanation ... Blackfan-Diamond anemia congenital hypoplastic anemia (def. 1).. congenital hypoplastic anemia idiopathic progressive anemia ... congenital hypoplastic anemia. Diamond-Blackfan anemia.. Cooley anemia. See: Cooley anemia. deficiency anemia. Anemia due to ...
Congenital. Explain Anemia, Hypoplastic, Congenital. What is Anemia, Hypoplastic, Congenital? Anemia, Hypoplastic, Congenital ... Anemia, Hypoplastic, Congenital. Medical Dictionary -> Anemia, Hypoplastic, Congenital. Search: Anemia, Hypoplastic, Congenital ... Hypoplastic, Congenital definition. define Anemia, Hypoplastic, ...
Congenital hypoplastic anemia associated with hypogammaglobulinemia. by E G Brookfield et al. ... Congenital hypoplastic anemia associated with hypogammaglobulinemia.. *. E G Brookfield. , Partipal Singh. *. Published. 1974. ... article{Brookfield1974CongenitalHA, title={Congenital hypoplastic anemia associated with hypogammaglobulinemia.}, author={E G ...
This is anemia resulting from failure to produce the formed elements of blood by the bone marrow. Morphologically, in the vast ... Causes of Aplastic Anemia. Primary: Acquired idiopathic congenital (Fanconis). Secondary: Chemicals and toxins including drugs ... All You Need To Know About Aplastic Anemia Or Bone Marrow Failure (Hypoplastic Anemia). Updated on January 20, 2014 ... Aplastic anemia is a rare disorder contributing to 1-2% of the total number of anemia cases. Males suffer twice as many as ...
"Anemia, Diamond-Blackfan (Congenital Hypoplastic Anemia)." Quick Medical Diagnosis & Treatment Pediatrics Hay, Jr WW, Levin MJ ... Anemia, Diamond-Blackfan (Congenital Hypoplastic Anemia). In: Hay, Jr WW, Levin MJ, Deterding RR, Abzug MJ. Hay, Jr W.W., Levin ... Horos R, von Lindern M: Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia. Br J Haematol 2012;159:514 ... Relatively rare cause of anemia that usually presents at 2-3 months of age ...
congenital hypoplastic anemia. .css-grsm00{display:none;position:absolute;bottom:0px;height:100px;background:linear-gradient( ...
CONGENITAL HYPOPLASTIC ANEMIA Howard A. Pearson, Thomas E. Cone. Pediatrics Feb 1957, 19 (2) 192-200; DOI: ... Multiple Serum Protein Deficiencies in Congenital and Acquired Agammaglobulinemia Pediatrics Feb 1957, 19 (2) 207; DOI: ...
Diamond-Blackfan anemia is a disorder that primarily affects the bone marrow. Explore symptoms, inheritance, genetics of this ... chronic congenital agenerative anemia. *congenital erythroid hypoplastic anemia. *congenital hypoplastic anemia of Blackfan and ... The resulting shortage of red blood cells (anemia. ) usually becomes apparent during the first year of life. Symptoms of anemia ... Haploinsufficiency of ribosomal proteins and p53 activation in anemia: Diamond-Blackfan anemia and the 5q- syndrome. Adv Biol ...
Anemia. Fanconi Anemia. Fanconi Syndrome. Hematologic Diseases. Anemia, Hypoplastic, Congenital. Anemia, Aplastic. Bone Marrow ... Genetic and Rare Diseases Information Center resources: Fanconi Anemia Congenital Aplastic Anemia Fanconi Syndrome Nephropathic ... Pilot Study of Metformin for Patients With Fanconi Anemia. The safety and scientific validity of this study is the ... This is a single institution, open-label, single arm pilot study of Metformin in patients with Fanconi Anemia (FA) and ...
Fanconi Anemia. Fanconi Syndrome. Anemia. Hematologic Diseases. Anemia, Hypoplastic, Congenital. Anemia, Aplastic. Bone Marrow ... Genetic and Rare Diseases Information Center resources: Aplastic Anemia Fanconi Anemia Congenital Aplastic Anemia Fanconi ... Fanconis Anemia Drug: filgrastim Genetic: Autologous stem cells transduced with FACC retroviral vector Procedure: Autologous ... Fanconis anemia, complementation group C (FACC) Confirmed by diepoxybutane or mitomycin testing AND DNA analysis indicating ...
Anemia, Hypoplastic, Congenital. Anemia, Aplastic. Red-Cell Aplasia, Pure. Genetic Diseases, Inborn. Lenalidomide. Immunologic ... Pilot Lenalidomide in Adult Diamond-Blackfan Anemia Patients w/ RBC Transfusion-Dependent Anemia. The safety and scientific ... Anemia. Myelodysplastic Syndromes. Anemia, Diamond-Blackfan. Neoplasms by Histologic Type. Neoplasms. Leukemia, Myeloid. ... A Pilot Study of Lenalidomide in Adult Diamond-Blackfan Anemia Patients With Red Blood Cell Transfusion-Dependent Anemia. ...
... there have been numerous direct and indirect scientific contributions to both the etiology and therapy of aplastic anemia and ... Congenital Hypoplastic Anemia (Diamond - Blackfan Anemia). Pages 166-178. Glader, Bertil E. ... Aplastic Anemia and Other Bone Marrow Failure Syndromes. Editors. * Nasrollah T. Shahidi ... Aplastic Anemia and Other Bone Marrow Failure Syndromes. Editors: Shahidi, Nasrollah T. (Ed.) ...
Acquired (autoimmune) hemolytic anemia. Erythroblastopenia (RBC anemia). Congenital (erythroid) hypoplastic anemia Neoplastic ... Congenital adrenal hyperplasia. Non suppurative thyroiditis. Hypercalcemia associated with cancer Rheumatic Disorders. As ...
Congenital (erythroid) hypoplastic anemia. This document does not contain all possible side effects and other serious side ...
Acquired (autoimmune) hemolytic anemia. Erythroblastopenia (RBC anemia). Congenital (erythroid) hypoplastic anemia. *Neoplastic ... Congenital adrenal hyperplasia. Nonsuppurative thyroiditis. Hypercalcemia associated with cancer. *Rheumatic Disorders: As ...
Acquired (autoimmune) hemolytic anemia. Erythroblastopenia (RBC anemia). Congenital (erythroid) hypoplastic anemia. 9. ...
anemia answers are found in the Tabers Medical Dictionary powered by Unbound Medicine. Available for iPhone, iPad, Android, ... congenital hypoplastic anemia. SEE: Diamond-Blackfan anemia.. Cooley anemia. SEE: Cooley anemia ... Anemia due to chronic disease. SYN: SEE: anemia of chronic inflammation; SEE: anemia of inflammation ... congenital hemolytic anemia. Any of a group of inherited chronic anemias marked by disintegration of red blood cells, jaundice ...
3 congenital dyserythropoietic anemia,4⇓-6 Diamond-Blackfan anemia,7,8 malarial anemia,9,10 and various bone marrow failure ... 16 congenital dyserythropoietic anemia,17⇓⇓-20 and Diamond-Blackfan anemia21,22 have been identified, the molecular basis for ... Congenital hypoplastic anemia. Adv Pediatr. 1976;22:349-378.. OpenUrlPubMed. *8.↵. *Lipton JM, ... Congenital dyserythropoietic anemia type I is caused by mutations in codanin-1. Am J Hum Genet. 2002;71(6):1467-1474. ...
Diamond-Blackfan anemia (DBA) is categorized as a congenital hypoplastic anemia, presenting during infancy with normochromic- ... DBA is a congenital hypoplastic anemia that develops within the first year of life, often with pallor as the only initial ... Defective erythroid progenitor differentiation system in congenital hypoplastic (Diamond-Blackfan) anemia. Blood 1986; 67:962- ... Diamond-Blackfan anemia (DBA) is a congenital erythroid aplasia that usually presents as macrocytic anemia during infancy. ...
Acquired (autoimmune) hemolytic anemia. Erythroblastopenia (RBC anemia). Congenital (erythroid) hypoplastic anemia. 9. ...
Acquired (autoimmune) hemolytic anemia Erythroblastopenia (RBC anemia) Congenital (erythroid) hypoplastic anemia * Neoplastic ... Congenital adrenal hyperplasia Nonsuppurative thyroiditis Hypercalcemia associated with cancer * Rheumatic Disorders As ...
  • The anaemia induced by B19 infection is of minor clinical significance in healthy children and adults, however, it becomes critical in those afflicted with haemolytic diseases. (deepdyve.com)
  • In this review, we address the clinical manifestations and molecular mechanisms for B19‐induced anaemia in humans and a mouse model, and of B19‐induced cell cycle arrests in erythroid cells. (deepdyve.com)
  • Diagnosing and treating Diamond Blackfan anaemia: results of an international clinical consensus conference," British Journal of Haematology , vol. 142, no. 6, pp. 859-876, 2008. (hindawi.com)
  • Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. (hindawi.com)
  • Its primary clinical applications include treatment of osteoporosis and anaemia, as well as stimulating muscle growth in malnourished or underdeveloped patients. (drugbank.ca)
  • This observational study will evaluate the clinical benefit of NeoRecormon (epoetin beta) in daily routine practice in cancer patients with anemia. (bioportfolio.com)
  • Diamond-Blackfan anemia (DBA) is a class of human diseases linked to defective ribosome biogenesis that results in clinical phenotypes. (biomedcentral.com)
  • This authoritative, clinical resource covers the scientific basis of the many forms of anemia, while offering a practical approach to prognosis, diagnosis and management. (icebe.es)
  • In a typical clinical picture they are: pale skin and mucosal, tachycardia, signs of bleeding diathesis (petechiae, ecchymosis, mucosal bleeding ) and recurrent or difficult [czytelniamedyczna.pl] Bone marrow aplasia may be either congenital or acquired. (symptoma.com)
  • Anemia, Diamond. (mhmedical.com)
  • Horos R, von Lindern M: Molecular mechanisms of pathology and treatment in Diamond Blackfan Anaemia. (mhmedical.com)
  • Diamond-Blackfan anemia is a disorder that primarily affects the bone marrow. (medlineplus.gov)
  • In Diamond-Blackfan anemia, the bone marrow malfunctions and fails to make enough red blood cells, which carry oxygen to the body's tissues. (medlineplus.gov)
  • People with Diamond-Blackfan anemia have an increased risk of several serious complications related to their malfunctioning bone marrow. (medlineplus.gov)
  • Individuals with Diamond-Blackfan anemia also have an increased risk of developing a bone marrow cancer known as acute myeloid leukemia (AML), a type of bone cancer called osteosarcoma, and other cancers. (medlineplus.gov)
  • The severity of Diamond-Blackfan anemia may vary, even within the same family. (medlineplus.gov)
  • Increasingly, individuals with "non-classical" Diamond-Blackfan anemia have been identified. (medlineplus.gov)
  • Diamond-Blackfan anemia affects approximately 5 to 7 per million newborn babies worldwide. (medlineplus.gov)
  • Diamond-Blackfan anemia can be caused by mutations in one of many genes, including the RPL5 , RPL11 , RPL35A , RPS10 , RPS17 , RPS19 , RPS24 , and RPS26 genes. (medlineplus.gov)
  • These and other genes associated with Diamond-Blackfan anemia provide instructions for making ribosomal proteins, which are components of cellular structures called ribosomes . (medlineplus.gov)
  • Approximately 25 percent of individuals with Diamond-Blackfan anemia have mutations in the RPS19 gene. (medlineplus.gov)
  • Abnormal regulation of cell division or inappropriate triggering of apoptosis may contribute to the other health problems that affect some people with Diamond-Blackfan anemia. (medlineplus.gov)
  • This is a single-center, single arm, open-label study of oral lenalidomide monotherapy administered to red blood cell (RBC) transfusion dependent adult subjects with Diamond-Blackfan Anemia (DBA). (clinicaltrials.gov)
  • 1 Already in 1938 L. K. Diamond and K. D. Blackfan discussed the cause of this bewildering disease and proposed: "…there may be congenital insufficiency of red marrow tissue and inability on the part of the hematopoietic system to respond to the need for more blood as the erythrocytes wear out. (bloodjournal.org)
  • CSA therapy should be tried in steroid-resistant Diamond-Blackfan anemia patients before blood transfusion or corticosteroid therapy complications are instituted. (aappublications.org)
  • Diamond Blackfan anemia is present at birth but can be difficult to identify. (verywellhealth.com)
  • Diamond Blackfan anemia usually is diagnosed when a baby is 3 or 4 months old, although it is sometimes detected at birth, based on symptoms. (verywellhealth.com)
  • Due to the fact that Diamond Blackfan anemia is extremely rare, and few physicians are familiar with it, it can take some time to arrive at a correct diagnosis. (verywellhealth.com)
  • This study will determine the safety and possibility of giving the amino acid, leucine, in patients with Diamond Blackfan anemia(DBA)who are on dependent on red blood cell transfusions. (stanford.edu)
  • L. K. Diamond and K. D. Blackfan, "Hypoplastic anemia," American Journal of Diseases of Children , vol. 56, pp. 464-467, 1938. (hindawi.com)
  • Bone marrow transplantation for Diamond-Blackfan anemia," Biology of Blood and Marrow Transplantation , vol. 11, no. 8, pp. 600-608, 2005. (hindawi.com)
  • The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia," Nature Genetics , vol. 21, no. 2, pp. 169-175, 1999. (hindawi.com)
  • Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackfan anemia," American Journal of Human Genetics , vol. 86, no. 2, pp. 222-228, 2010. (hindawi.com)
  • Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia," American Journal of Human Genetics , vol. 79, no. 6, pp. 1110-1118, 2006. (hindawi.com)
  • Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients," American Journal of Human Genetics , vol. 83, no. 6, pp. 769-780, 2008. (hindawi.com)
  • The ribosomal basis of Diamond-Blackfan anemia: mutation and database update," Human Mutation , vol. 31, no. 12, pp. 1269-1279, 2010. (hindawi.com)
  • Missense mutations associated with Diamond-Blackfan anemia affect the assembly of ribosomal protein S19 into the ribosome. (sigmaaldrich.com)
  • Mutations in this gene are found in Diamond-Blackfan anemia 10. (genecards.org)
  • Diseases associated with RPS26 include Diamond-Blackfan Anemia 10 and Diamond-Blackfan Anemia 15 With Mandibulofacial Dysostosis . (genecards.org)
  • Diamond Blackfan Anemia (DBA) was first recognized as a distinct entity in 1938, although it was called "congenital hypoplastic anemia" at that time. (squarespace.com)
  • Diamond Blackfan Anemia ("DBA") is a rare blood disorder, characterized by a failure of the bone marrow (the center of the bone where blood cells are made) to produce red blood cells. (squarespace.com)
  • 3 The identification of the affected gene in a congenital disorder, such as DBA, is often the key that suddenly enables understanding of the molecular pathogenesis and development of novel therapies. (bloodjournal.org)
  • There is retardation of hemoglobin A synthesis in the heterozygous form (thalassemia minor), which is asymptomatic, while in the homozygous form (thalassemia major, Cooley's anemia, Mediterranean anemia, erythroblastic anemia), which can result in severe complications and even death, hemoglobin A synthesis is absent. (bioportfolio.com)